A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1176/appi.ajp.164.5.797PMID 17475739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

  2008cited by this paper
• Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.

  2007cited by this paper
• Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.

  2006cited by this paper
• Is methadone too dangerous for opiate addiction

  2006cited by this paper
• Methods for Assessing Noninferiority with Censored Data

  2005cited by this paper
• Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998-2002.

  2005cited by this paper
• Is methadone too dangerous for opiate addiction?

  2005cited by this paper
• Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.

  2005cited by this paper
• Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.

  2005cited by this paper
• 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.

  2003influential reference
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2003cited by this paper
• Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.

  2003cited by this paper
• Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients.

  2003cited by this paper
• Treatment characteristics and retention in methadone maintenance: High and stable retention rates in a Swedish two-phase programme

  2002cited by this paper
• Pharmacotherapy of addictions

  2002cited by this paper
• Buprenorphine: blending practice and research.

  2002cited by this paper
• Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

  2001cited by this paper
• Death attributed to methadone.

  2001cited by this paper
• Deaths attributable to methadone vs buprenorphine in France.

  2001cited by this paper
• Buprenorphine and Naloxone for Heroin Dependence

  2000influential reference
• Stepped care as a heuristic approach to the treatment of alcohol problems.

  2000cited by this paper
• A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

  2000cited by this paper
• Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study

  2000cited by this paper
• A COMPARISON OF LEVOMETHADYL ACETATE , BUPRENORPHINE , AND METHADONE FOR OPIOID DEPENDENCE

  2000cited by this paper
• An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model.

  1997cited by this paper
• A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.

  1996cited by this paper
• Methadone maintenance and addicts' risk of fatal heroin overdose.

  1996cited by this paper
• Long-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid Antagonists and Partial Agonists

  1996cited by this paper
• Clinic policy and retention in methadone maintenance.

  1993cited by this paper
• The Fifth Edition of the Addiction Severity Index.

  1992cited by this paper
• Mortality in heroin addiction: impact of methadone treatment

  1990cited by this paper
• Relapse prevention: introduction and overview of the model.

  1984cited by this paper
• Sample size graphs for "proving the null hypothesis".

  1984cited by this paper
• The Swedish methadone maintenance program: a controlled study.

  1981cited by this paper

• Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl era.

  2026cites this paper
• Association between buprenorphine adherence for opioid use disorder and clinical events and healthcare spending among older patients.

  2025cites this paper
• Relative risks of adverse effects across different opioid agonist treatments-A systematic review and meta-analysis.

  2025cites this paper
• Approved medications for opioid use disorder : current update

  2025cites this paper
• The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021.

  2025cites this paper
• The Importance of Treatment Modality in Veterans with Opioid Use Disorder: Implications for Virtual Care

  2024cites this paper
• Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial

  2024cites this paper
• Janus LAAM-loaded electrospun fibrous buccal films for treating opioid use disorder.

  2024cites this paper
• Evidence on Buprenorphine Dose Limits: A Review

  2023cites this paper
• Higher buprenorphine dose associated with increased treatment retention at low threshold buprenorphine clinic: A retrospective cohort study.

  2023cites this paper
• Malmö Treatment Referral and Intervention Study (MATRIS)-36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment-The role of stimulant use at baseline.

  2023cites this paper
• Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial.

  2023cites this paper
• Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.

  2023cites this paper
• The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

  2023cites this paper
• Endomorphin analog ZH853 shows low reward, tolerance, and affective-motivational signs of withdrawal, while inhibiting opioid withdrawal and seeking.

  2023cites this paper
• Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl

  2023cites this paper
• THE EFFECT OF CHRONIC STRESS ON THE IMMUNOGENICITY AND IMMUNOPROTECTION OF THE M6-TT VACCINE IN FEMALE MICE.

  2023cites this paper
• Psychotherapies in opioid use disorder: toward a step-care model

  2023cites this paper
• Patient reported goals for medications for opioid use disorder: A theory of proximal goal attainment

  2023cites this paper
• A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder

  2022cites this paper
• The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review

  2022cites this paper
• Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.

  2022cites this paper
• Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials

  2022cites this paper
• Buprenorphine reduces methamphetamine intake and drug seeking behavior via activating nociceptin/orphanin FQ peptide receptor in rats

  2022cites this paper
• Changes in opioid-related deaths following increased access to opioid substitution treatment

  2021cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2020cites this paper
• Medication Treatment of Opioid Use Disorder.

  2020cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2020cites this paper
• Improving translation of animal models of addiction and relapse by reverse translation

  2020cites this paper
• Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.

  2020cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2020cites this paper
• Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data

  2020cites this paper
• Opioid Treatments for Chronic Pain

  2020cites this paper
• Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.

  2020cites this paper
• Changes in opioid mortality following increased access to opioid substitution treatment

  2020cites this paper
• Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances

  2020cites this paper
• Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration.

  2020cites this paper
• Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.

  2020cites this paper
• Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada

  2020cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2020cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2020cites this paper
• Improving translation of animal models of addiction and relapse by reverse translation

  2020cites this paper
• Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

  2019cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2019cites this paper
• Bupenorphine in Wisconsin Drivers: Concerns for Impairment?

  2019cites this paper
• The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

  2019cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2019cites this paper
• Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals

  2019cites this paper
• Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment

  2019cites this paper
• Increasing diversion of methadone in Vancouver, Canada, 2005-2015.

  2018cites this paper
• Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption

  2018cites this paper
• Buprenorphine and the Opioid Crisis: A Primer for Congress [December 7, 2018]

  2018cites this paper
• Key Populations: Identification and Management of HCV in People Who Inject Drugs

  2018cites this paper
• Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder

  2018cites this paper
• HCV Guidance References

  2018cites this paper
• Management of opioid use disorders: a national clinical practice guideline

  2018cites this paper
• Unique Populations

  2018cites this paper
• Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures.

  2018cites this paper
• Opioid substitution treatment is linked to reduced risk of death in opioid use disorder

  2017cites this paper
• Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?

  2017cites this paper
• The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

  2017cites this paper
• Prise en charge des troubles de consommation d’opioïdes en première ligne

  2017cites this paper
• Overcoming Barriers to Initiating Medication-assisted Treatment for Heroin Use Disorder in a General Medical Hospital: A Case Report and Narrative Literature Review

  2017cites this paper
• Malmö Treatment Referral and Intervention Study—High 12-Month Retention Rates in Patients Referred from Syringe Exchange to Methadone or Buprenorphine/Naloxone Treatment

  2017cites this paper
• Prise en charge des troubles de consommation d’opioïdes en première ligne: Abstinence, méthadone ou buprénorphine-naloxone?

  2017cites this paper
• Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

  2017cites this paper
• Probuphine® (buprenorphine implant): a promising candidate in opioid dependence

  2017cites this paper
• Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy

  2017cites this paper
• Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.

  2017cites this paper
• Treatment of opioid dependence with buprenorphine: current update

  2017cites this paper
• Prescription drug abuse - A timely update.

  2016cites this paper
• Malmö Treatment Referral and Intervention Study (MATRIS)—effective referral from syringe exchange to treatment for heroin dependence: a pilot randomized controlled trial.

  2016cites this paper
• Medication-Assisted Treatment for Pregnant Women: An Interdisciplinary Group Based Model

  2016cites this paper
• What Works? A Meta-Analysis of Quantitative Studies Regarding Heroin Policy

  2016cites this paper
• Sacred Cows and Greener Pastures: Reflections from 40 Years in Addiction Research

  2016cites this paper
• Does the combination of buprenorphine/naltrexone have antidepressant efficacy in animal models?

  2016cites this paper
• Systematic Literature Review on Buprenorphine/naloxone Use in Outpatient Opioid Dependence Treatment

  2016cites this paper
• Medication-assisted treatment for substance use disorders within a national community health center research network

  2016cites this paper
• Risker och sidoeffekter i läkemedelsassisterad rehabilitering av opioidberoende – en forskningsöversikt

  2016cites this paper
• Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment.

  2016cites this paper
• Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study

  2016cites this paper
• 10 Maintenance treatment

  2016cites this paper
• Developing a patient-driven, substantive definition of office-based opioid treatment success

  2016cites this paper
• New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone

  2015cites this paper
• Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.

  2015cites this paper
• Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden

  2015cites this paper
• Current Status of Buprenorphine/Naloxone Maintenance Treatment in Istanbul Turkey

  2015cites this paper
• Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update

  2015cites this paper
• Pharmacological Management of Opioid Use Disorder in Pregnant Women

  2015cites this paper
• Buprenorphine for Pain and Opioid Dependence

  2015cites this paper
• Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study

  2015cites this paper
• A Comparison of Pregnancy-Only versus Mixed-Gender Group Therapy among Pregnant Women with Opioid Use Disorder

  2015cites this paper
• Pharmacotherapy of Alcohol and Drug Dependence

  2015cites this paper
• Pilot testing of an online training for criminal justice professionals on medication-assisted treatment

  2015cites this paper
• Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.

  2015cites this paper
• Drug and alcohol addiction: new pharmacotherapies

  2015cites this paper
• Medication-AssistedTreatmentWith Buprenorphine:AssessingtheEvidence

  2014cites this paper
• Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

  2014cites this paper
• Therapeutic Class Overview

  2014cites this paper
• Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence

  2014cites this paper